Previous close | 0.2130 |
Open | 0.2190 |
Bid | 0.3150 x 100 |
Ask | 0.5460 x 200 |
Day's range | 0.2121 - 0.5690 |
52-week range | 0.2000 - 2.0460 |
Volume | |
Avg. volume | 763,753 |
Market cap | 3.826M |
Beta (5Y monthly) | 1.69 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.2300 |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.00 |
iSpecimen Inc. (NASDAQ:ISPC) Q4 2023 Earnings Call Transcript March 14, 2024 iSpecimen Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone, and welcome to iSpecimen’s Full-Year 2023 Results Conference Call. At this time, all participants are in […]
iSpecimen ( NASDAQ:ISPC ) Full Year 2023 Results Key Financial Results Revenue: US$9.93m (down 4.6% from FY 2022). Net...
LEXINGTON, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the twelve-month period ended December 31, 2023. “Throughout 2023, we advanced our objective to reach profitability, focusing on right-sizing our business and implementing new operati